True or False: Ipratropium has a short duration of action.

Ipratropium has a relatively short duration of action, typically lasting around 4 to 6 hours after administration. This property makes it suitable for use in conditions such as asthma and chronic obstructive pulmonary disease (COPD), where it can provide relief for a limited time and often needs to be administered multiple times throughout the day for optimal control.

While it is effective, its short duration means that patients often rely on it in conjunction with other longer-acting bronchodilators to manage symptoms over the course of the day. Such information illustrates that dosing schedules should be tailored to the severity of the condition and the patient's response to the medication.

Understanding these characteristics helps clinicians and patients make informed decisions regarding the management of respiratory conditions, particularly in situations requiring quick relief but with the knowledge that additional doses may be necessary throughout the day.